Sleep stack
Epithalon + DSIP — circadian reset & deep sleep
1.710.000 ₫
Vial-by-vial breakdown
A two-peptide pre-bed protocol designed to deepen sleep architecture and restore the circadian signalling that governs it. DSIP (delta sleep-inducing peptide) is the only peptide named for and characterised by a direct effect on slow-wave (delta) sleep architecture in published human work — no other peptide in the category has equivalent EEG-validated delta-wave evidence. Unlike sedative GABAergics it doesn't suppress REM; it deepens what is already there. Epithalon is paired because it acts upstream on the pineal–melatonin axis: in the Khavinson clinical programme it restored night-time melatonin secretion and normalised circadian rhythm in older adults, with telomere-maintenance effects documented in long-term follow-up. DSIP deepens the sleep itself; Epithalon re-sets the clock that schedules it. Both dosed in short evening cycles to avoid tolerance.
Dosage
DSIP: 100–300 mcg pre-bed · Epithalon: 5–10 mg nightly in 10–20 day cycles
Key Features
- Pre-bed deep sleep + neural repair
- Delta-wave architecture support
- Short cyclical dosing
- 10% stack discount
Includes key details, half-life data, usage notes and research sources.
Usage Instructions
Subcutaneous injection as recommended. Consult a healthcare professional for protocols tailored to your goals.
Research Highlights
- Backed by scientific research
- Manufactured to pharmaceutical standards
- Used in clinical research settings
- Established safety profile
Safety Information
- •Consult your healthcare provider before use
- •Not intended for pregnant or nursing women
- •Store properly according to instructions
- •Report any adverse effects to your healthcare provider
Source: Kovalzon & Strekalova, PNAS (PMC, 1979)
Clinical Research
Delta sleep-inducing peptide significantly increases slow-wave (delta) sleep and supports sleep-related growth hormone release — the foundational evidence that DSIP, the primary component of this stack, deepens sleep architecture rather than acting as a sedative.
Read full studyAdditional Research
Source: Khavinson et al., Bull. Exp. Biol. Med. (2003)
In the Khavinson clinical programme, Epithalon restored night-time melatonin secretion and normalised circadian rhythm in older adults, with long-term follow-up documenting telomere maintenance and reduced mortality in the treated groups.
Read full studyHuman Clinical Trials
- DSIP in chronic insomniaNeuropsychobiology · 1981
Double-blind placebo-controlled crossover study in insomnia patients; clinical benefit was modest and inconsistent.
Small, old study with weak results.
Read the trial16participants